ISSCA Launches “Signature,” a New Certification Format, with a Pilot Edition in Bali
MIAMI / BALI — The International Society for Stem Cell Application (ISSCA) is introducing ISSCA Signature, a certification format held for a focused group of physicians in a single city, separate from the organization’s numbered international congresses.
The pilot edition, ISSCA Signature — Bali, takes place November 2 to 4, 2026, at Jl. Sunset Road No. 101E, Kuta, Bali. Unlike ISSCA’s flagship congresses, which gather roughly a thousand physicians around simultaneous certifications, the Signature format places a focused group in direct, sustained contact with the faculty across three days, with no parallel conference program.
Over three days, participating physicians certify across peptide therapy, MUSE cell technology, cancer immunology, and dendritic cell and NK cell approaches, with the program structured so that each area translates into applied capability in the physician’s own practice.
The certification is issued as the Advanced Cellular Therapeutics & Immuno-Oncology Certification, and the program is directed at licensed physicians.
ISSCA is an academic institution in regenerative medicine based in Miami. In 16 years of trajectory it has certified more than 10,000 physicians across more than 40 countries and runs more than 17 international congresses a year.
Media and physician inquiries: info@stemcellsgroup.com
